| Financial Year |
March 31 2023 |
| Monetary Funds |
4,430,320,740.86 |
| Held-for-trading Financial Assets |
61,910,154.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
202,672,138.66 |
| Advances to Suppliers |
15,378,013.37 |
| Other Receivables |
116,447,499.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
20,798,599,105.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
443,331,830.19 |
| Total Current Assets |
26,068,659,482.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,157,815,996.75 |
| Investment Properties |
2,654,714,870.06 |
| Fixed Assetes |
754,600,766.79 |
| Under-construction Projects |
40,341,374.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,035,721.80 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
84,588,423.09 |
| Deferred Income Tax Assets |
375,469,318.07 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,195,716,235.73 |
| Total Assets |
32,264,375,717.84 |
| Short-Term Loans |
1,443,896,393.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,617,167,274.11 |
| Accounts Received In Advance |
223,367.00 |
| Employee Compensation Payable |
10,839,015.68 |
| Taxes Payable |
110,456,225.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,471,865,816.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,246,279,740.90 |
| Other Current Liabilities |
418,434,173.19 |
| Sub-Total of Current Liabilities |
19,513,468,150.84 |
| Long-term Loans |
5,681,768,818.66 |
| Bonds Payable |
398,417,534.25 |
| Long-Term Accounts Payable |
94,889,303.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,040,362.58 |
| Deferred Income Tax Liabilities |
207,988,560.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,411,467,326.15 |
| Total Liabilities |
25,924,935,476.99 |
| Paid-In Capital(Or Share Stock) |
1,885,005,795.00 |
| Capital Surplus |
540,521,114.06 |
| Surplus Reserve |
332,374,160.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,841,756,450.63 |
| Minority Stockholder's Interest |
-2,402,986.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,341,843,227.83 |
| Owner's Equity（Stockholder's Equity） |
6,339,440,240.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,264,375,717.84 |
